Trial Profile
E3810-A001-312: Efficacy and Safety of 10 Mg Rabeprazole for Treating Heartburn in Frequent Sufferers
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Nov 2009
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary)
- Indications Heartburn
- Focus Therapeutic Use
- 25 Feb 2009 Additional lead trial investigator identified as reported by ClinicalTrials.gov, last updated 25-Feb-2009.
- 25 Feb 2009 Actual patient number (619) added as reported by ClinicalTrials.gov.
- 24 Jun 2008 Actual end date for this trial is now Jun 2008 as reported by ClinicalTrials.gov